Photobiomodulation Applications in Clinical Veterinary Surgery: Current Status and Future Perspectives
Photobiomodulation (PBM) has emerged as a noninvasive therapeutic tool with promising clinical applications in veterinary clinical surgery. Its mechanism of action is based on the stimulation of cellular processes through low-intensity light, promoting adenosine triphosphate production, inflammatory...
| Autores: | , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2026 |
| País: | España |
| Institución: | Universidad de Santiago de Compostela (USC) |
| Repositorio: | Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela |
| Idioma: | inglés |
| OAI Identifier: | oai:minerva.usc.gal:10347/45863 |
| Acceso en línea: | https://hdl.handle.net/10347/45863 |
| Access Level: | acceso abierto |
| Palabra clave: | Photobiomodulation Near-infrared light Light-tissue interaction Veterinary clinical surgery Therapeutic laser Healing Analgesia Postoperative rehabilitation Low-level laser therapy Tissue biomodulation |
| Sumario: | Photobiomodulation (PBM) has emerged as a noninvasive therapeutic tool with promising clinical applications in veterinary clinical surgery. Its mechanism of action is based on the stimulation of cellular processes through low-intensity light, promoting adenosine triphosphate production, inflammatory modulation, and tissue regeneration. This narrative review examines the current state of knowledge on the use of PBM in veterinary surgical contexts, with an emphasis on its clinical application in wound healing, postoperative pain control, and functional recovery. The physiological foundations of the technique, the main technical parameters that determine its effectiveness (wavelength, dose, frequency, and mode of application), and the available clinical evidence from different specialties such as soft tissue surgery, orthopedics, dentistry, and neurosurgery are analyzed. Current limitations, such as the lack of standardized protocols and their limited inclusion in clinical guidelines, are also addressed, as are future opportunities related to treatment personalization, the development of specific veterinary devices, and integration with emerging technologies. PBM represents a safe and effective adjuvant therapeutic strategy with the potential to become an integral part of veterinary postoperative management. |
|---|